Gabapentin Capsule
Product Images NDC 43547-481

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43547-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01 (Image 01)

An equation representing creatinine clearance (CLCr) calculation based on age (years), weight (kg), serum creatinine (mg/dL), and a factor for female patients (0.85). It is part of a drug facts or clinical calculation panel.*

FDA Label Image

Image 02 Structural Formula (Image 02)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group and a carboxylic acid group.*

FDA Label Image

Image03 (Image 03)

This line graph depicts mean pain scores over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The x-axis shows time in weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain score values from 0 to 10. Gabapentin shows a decreasing mean pain score trend over time, while placebo remains relatively constant.*

FDA Label Image

Image04 (Image 04)

A line graph showing mean pain score over 7 weeks for three groups: Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, while the y-axis shows mean pain score ranging from 0 to 10. The graph distinguishes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Image05 (Image 05)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows 12% response for placebo versus 29% for GBP 3600 mg. Study 2 shows 14% response for placebo versus 32% and 34% for GBP 1800 mg and GBP 2400 mg, respectively, with statistical significance indicated.*

FDA Label Image

Image06 (Image 06)

A scatter plot showing the difference (%) on the vertical axis versus daily dose (mg) on the horizontal axis for Gabapentin oral capsules in three studies labeled a, b, and c. The plot compares differences across doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg, with study-specific symbols and letters indicating data points.*

FDA Label Image

100 mg (Image 07)

Label for Gabapentin Capsules, USP 100 mg, oral dosage form. The label states the product is distributed by Solco Healthcare US, LLC and manufactured by Zhejiang Huahai Pharmaceutical Technology Co., Ltd. It contains 500 capsules. The label includes storage instructions, prescribing information links, and a pharmacist dispensing note. The design features a blue background with white text and a red gradient band indicating the strength.*

FDA Label Image

300 mg (Image 08)

Gabapentin Capsules, USP 300 mg oral capsules label from Solco Healthcare US, LLC. The label indicates prescription use only, a package size of 500 capsules, and provides storage instructions. It includes manufacturer and distributor details as well as references for prescribing information and medication guides.*

FDA Label Image

400 mg (Image 09)

Label for Gabapentin Capsules, USP 400 mg by Solco Healthcare US, LLC. The label indicates 100 capsules per package, includes dosage and use instructions referencing the full prescribing information, and provides storage conditions. Manufactured by Zhejiang Huahai Pharmaceutical Technology Co., Ltd., China, and distributed by Solco Healthcare US, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.